User profiles for C. D. Fell

Charlene D Fell

University of Calgary
Verified email at ucalgary.ca
Cited by 2316

Pulmonary manifestations of systemic lupus erythematosus

S Mittoo, CD Fell - Seminars in respiratory and critical care …, 2014 - thieme-connect.com
Systemic lupus erythematosus (SLE) is a systemic inflammatory disease, characterized
serologically by an autoantibody response to nucleic antigens, and clinically by injury and/or …

Clinical predictors of a diagnosis of idiopathic pulmonary fibrosis

CD Fell, FJ Martinez, LX Liu, S Murray… - American journal of …, 2010 - atsjournals.org
… 6MWT data include the distance walked and whether the patient's oxygen saturation fell
below 88% … ‡ Number of patients whose oxygen saturation fell below 88% during the 6MWT. …

Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled …

…, NA Khalidi, CJ Ryerson, AW Wong, CD Fell… - The Lancet …, 2023 - thelancet.com
Background Interstitial lung disease is a known complication of rheumatoid arthritis, with a
lifetime risk of developing the disease in any individual of 7ˇ7%. We aimed to assess the safety…

Use of mycophenolate mofetil or azathioprine for the management of chronic hypersensitivity pneumonitis

…, C Aravena, BM Elicker, KD Jones, CD Fell… - Chest, 2017 - Elsevier
Background The treatment of chronic hypersensitivity pneumonitis (cHP) often includes
systemic oral corticosteroids, but the optimal pharmacologic management remains unclear. The …

Idiopathic pulmonary fibrosis: phenotypes and comorbidities

CD Fell - Clinics in chest medicine, 2012 - chestmed.theclinics.com
Idiopathic pulmonary fibrosis (IPF) is a progressive fatal disease of the lung with unknown
etiology and limited treatment options. Once thought to be slowly progressive disease, more …

Prevalence and characteristics of progressive fibrosing interstitial lung disease in a prospective registry

…, D Assayag, KA Johannson, CD Fell… - European …, 2022 - Eur Respiratory Soc
… Conflict of interest: CD Fell reports educational grants and research grants from Boehringer
Ingelheim, Roche and the Canadian Pulmonary Fibrosis Foundation; personal fees from …

Safety of nintedanib added to pirfenidone treatment for idiopathic pulmonary fibrosis

KR Flaherty, CD Fell, JT Huggins… - European …, 2018 - Eur Respiratory Soc
CD Fell has received consultant and research support fees from F. Hoffmann-La Roche
Canada and consultant fees from Boehringer Ingelheim. JT Huggins has received consultant …

The prognostic value of cardiopulmonary exercise testing in idiopathic pulmonary fibrosis

CD Fell, LX Liu, C Motika, EA Kazerooni… - American journal of …, 2009 - atsjournals.org
Rationale: Idiopathic pulmonary fibrosis (IPF) is characterized by progressive dyspnea,
impaired gas exchange, and ultimate mortality. Objectives: To test the hypothesis that maximal …

Sex differences in physiological progression of idiopathic pulmonary fibrosis

MK Han, S Murray, CD Fell, KR Flaherty… - European …, 2008 - Eur Respiratory Soc
In idiopathic pulmonary fibrosis, incidence is higher in males, and females may have better
survival. The aim of the present study was to determine whether the rate of increase in …

[HTML][HTML] Baseline characteristics and comorbidities in the CAnadian REgistry for Pulmonary Fibrosis

…, N Hambly, AJ Halayko, AS Gershon, CD Fell… - BMC pulmonary …, 2019 - Springer
Background The CAnadian REgistry for Pulmonary Fibrosis (CARE-PF) is a multi-center,
prospective registry designed to study the natural history of fibrotic interstitial lung disease (ILD) …